MEDIGENE
MDG1.DEMedigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. With its scientific expertise, Medigene is working on the development of innovative immunotherapies to treat cancer such as T cell receptor-modifie …
© Wikipedia /
Creative Commons CC-BY-SA 3.0
more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at MEDIGENE
Subscribe RSS| Date | Type | Ø-Price | Volume |
|---|---|---|---|
| 5/13/2024 | Buy | €1.2 | €12,000 |
| 5/13/2024 | Buy | €1.2 | €32,400 |
| 5/13/2024 | Buy | €1.2 | €6,964 |
| 5/10/2024 | Buy | €1.2 | €60,000 |
| 5/8/2024 | Buy | €1.6 | €3,875 |
All information without guarantee! No recommendation/consultation! © Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin)